Depomed recalls type 2 diabetes drug Glumetza
Drug developer Depomed Inc announced it would recall 52 lots of its type 2 diabetes drug Glumetza due to the presence of traces of a certain chemical in the tablet's 500 mg bottle, according to a Reuters report.
- Drug developer Depomed Inc said it will recall 52 lots of its diabetes drug Glumetza due to the presence of traces of a certain chemical in the tablet's 500 mg bottle.